Pacific Edge Ltd

Pacific Edge Ltd

Health CarePharmaceuticals and Biotechnology
  • Price (NZD)0.50
  • Today's Change0.00 / 0.00%
  • Shares traded432.44k
  • 1 Year change-54.95%
  • Beta1.6538
Data delayed at least 20 minutes, as of Feb 03 2023 04:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • PEB:NZC price moved over +2.00% to 0.51
  • PEB:NZC price falls below 15-day moving average to 0.495 at 14:20 GMT
  • PEB:NZC price falls below 15-day moving average to 0.50 at 09:59 GMT
  • PEB:NZC price rises above 15-day moving average to 0.51 at 10:03 GMT

Key statistics

On Friday, Pacific Edge Ltd (PEB:NZC) closed at 0.50, 25.00% above the 52 week low of 0.40 set on Aug 01, 2022.
52-week range
0.40Aug 01 20221.11Feb 04 2022
Markit short selling activity
Previous close0.50
Average volume539.79k
Shares outstanding810.37m
Free float746.84m
P/E (TTM)--
Market cap405.18m NZD
EPS (TTM)-0.0267
Data delayed at least 20 minutes, as of Feb 03 2023 04:00 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.